(Q53339087)

English

Calibration of disk diffusion antibiotic susceptibility testing: species-related trovafloxacin interpretive zone breakpoints and selection of disk potency.

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

Calibration of disk diffusion antibiotic susceptibility testing: species-related trovafloxacin interpretive zone breakpoints and selection of disk potency. (English)

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

author name string

Kronvall G

1

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

Rylander M

2

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

Walder M

3

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

Lind-Brandberg L

4

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

Larsson P

5

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

Törnqvist E

6

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

Monsen T

7

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

publication date

1 January 1999

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

Scandinavian Journal of Infectious Diseases

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

31

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

6

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

573-578

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

The chemistry and biological profile of trovafloxacin

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164463

21 January 2018

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164463

21 January 2018

Response to Ian Phillips and Anna King.

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164463

21 January 2018

Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164463

21 January 2018

In vitro activity of trovafloxacin versus ciprofloxacin against clinical isolates

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164463

21 January 2018

In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164463

21 January 2018

Identifiers

10.1080/00365549950164463

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/10680988

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53339087&oldid=1363113317"